Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children

References

• Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298–304
   PubMed Web of Science ®Google Scholar
• Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green HR, Bradding P, et al. Evidence of a role of tumor necrosis factor α in refractory asthma. N Engl J Med 2006;354:697–708
   PubMed Web of Science ®Google Scholar
• Brightling C, Berry M, Amrani Y. Targeting TNF-α: a novel therapeutic approach for asthma. J Allergy Clin Immunol 2008;121:5–10
   PubMed Web of Science ®Google Scholar
• Barnes PJ. New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 2007;119:1055–1062
   PubMed Web of Science ®Google Scholar
• Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479–490
   PubMed Web of Science ®Google Scholar
• Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 2007;104:282–287
   PubMed Web of Science ®Google Scholar
• Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A, Nambu A, et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA 2010;107:18581–18586
   PubMed Web of Science ®Google Scholar
• Lloyd CM. IL-33 family members and asthma – bridging innate and adaptive immune responses. Curr Opin Immunol 2010;22:800–806
   PubMed Web of Science ®Google Scholar
• Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Kuchler AM. Interleukin-33 cytokine of dual function or novel alarmin? Trends Immunol 2009;30:227–233
   PubMed Web of Science ®Google Scholar
• Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, von Mutius E, et al. A large-scale, consortium-based genome wide association study of asthma. N Engl J Med 2010;363:1211–1221
   PubMed Web of Science ®Google Scholar
• Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM, Thorleifsson G. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009;41:342–347
   PubMed Web of Science ®Google Scholar
• Wjst M, Sargurupremraj M, Arnold M. Genome-wide association studies in asthma: what they really told us about pathogenesis. Curr Opin Allergy Clin Immunol 2013;13:112–118
   PubMed Web of Science ®Google Scholar
• Borish L, Steinke JW. Interleukin-33 in asthma: how big of a role does it play? Curr Allergy Asthma Rep 2011;11:7–11
   PubMed Web of Science ®Google Scholar
• Xu D, Chan WL, Leung BP, Huang FP, Wheeler R, Piedrafita D, Robinson JH, Liew FY. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998;187:787–794
   PubMed Web of Science ®Google Scholar
• Koyasu S, Moro K. Innate Th2-type immune responses and the natural helper cell, a newly identified lymphocyte population. Curr Opin Allergy Clin Immunol 2011;11:109–114
   PubMed Web of Science ®Google Scholar
• Grotenboer NS, Ketelaar ME, Koppelman GH, Nawijn MC. Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology. J Allergy Clin Immunol 2013;131:856–865
   PubMed Web of Science ®Google Scholar
• Bianchetti L, Marini MA, Isgrò M, Bellini A, Schmidt M, Mattoli S. IL-33 promotes the migration and proliferation of circulating fibrocytes from patients with allergen-exacerbated asthma. Biochem Biophys Res Commun 2012;426:116–121
   PubMed Web of Science ®Google Scholar
• Préfontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, Lemière C, et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009;183:5094–5103
   PubMed Web of Science ®Google Scholar
• Préfontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, Martin JG, Hamid Q. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010;125:752–754
   PubMed Web of Science ®Google Scholar
• Iwahana H, Yanagisawa K, Ito-Kosaka A, Kuroiwa K, Tago K, Komatsu N, Katashima R, et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur J Biochem 1999;264:397–406
   PubMedGoogle Scholar
• Brunner M, Krenn C, Roth G, Moser B, Dworschak M, Jensen-Jarolim E, Spittler A, et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intens Care Med 2004;30:1468–1473
   PubMed Web of Science ®Google Scholar
• Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S, Solomon SD, Rouleau JL, Lee RT. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 2002;106:2961–2966
   PubMed Web of Science ®Google Scholar
• Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S, Tominaga SI, Sugiyama Y. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001;164:277–281
   PubMed Web of Science ®Google Scholar
• Nabe T. Tumor necrosis factor alpha-mediated asthma? Int Arch Allergy Immunol 2013;160:111–113
   PubMed Web of Science ®Google Scholar
• Van Weel C, Bateman ED, Bousquet J, Reid J, Grouse L, Schermer T, Valovirta E, Zhong N. Asthma management pocket reference 2008. Allergy 2008;63:997–1004
   PubMed Web of Science ®Google Scholar
• Hamzaoui A, Maalmi H, Berraïes A, Abid H, Ammar J, Hamzaoui K. Transcriptional characteristics of CD4 T cells in young asthmatic children: RORC and FOXP3 axis. J Inflamm Res 2011;4:139–146
   PubMedGoogle Scholar
• Hamzaoui A, Ammar J, Hamzaoui K. Regulatory T cells in induced sputum of asthmatic children: association with inflammatory cytokines. Multidiscip Respir Med 2010;5:22–30
   PubMed Web of Science ®Google Scholar
• Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili Boussen I, Haj Sassi F. Serum IL-33 levels and skin mRNA expression in Behçet’s disease. Clin Exp Rheumatol 2013. PubMed PMID: 23464866
   Google Scholar
• Chu DK, Llop-Guevara A, Walker TD, Flader K, Goncharova S, Boudreau JE, Moore CL, et al. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J Allergy Clin Immunol 2013;131:187–200
   PubMed Web of Science ®Google Scholar
• Hardman CS, Panova V, McKenzie AN. IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur J Immunol 2013;43:488–498
   PubMed Web of Science ®Google Scholar
• Smithgall MD, Comeau MR, Yoon BR, Kaufman D, Armitage R, Smith DE. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 2008;20:1019–1030
   PubMed Web of Science ®Google Scholar
• Ali M, Zhang G, Thomas WR, McLean CJ, Bizzintino JA, Laing IA, Martin AC, et al. Investigations into the role of ST2 in acute asthma in children. Tissue Antigens 2009;73:206–212
   PubMedGoogle Scholar
• Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007;282:26369–26380
   PubMed Web of Science ®Google Scholar
• Yin H, Li XY, Liu T, Yuan BH, Zhang BB, Hu SL, Gu HB, et al. Adenovirus-mediated delivery of soluble ST2 attenuates ovalbumin-induced allergic asthma in mice. Clin Exp Immunol 2012;170:1–9
   Google Scholar
• Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008;121:1484–1490
   PubMed Web of Science ®Google Scholar
• Moulin D, Donzé O, Talabot-Ayer D, Mézin F, Palmer G, Gabay C. Interleukin (IL)-33 induces the release of proinflammatory mediators by mast cells. Cytokine 2007;40:216–225
   PubMed Web of Science ®Google Scholar
• Chiang CH, Chuang CH, Liu SL, Shen HD. Genetic polymorphism of transforming growth factor-β1 and tumor necrosis factor-α is associated with asthma and modulate the severity of asthma. Respir Care 2013 [Epub ahead of print]
   Google Scholar
• Lugogo NL, Hollingsworth JW, Howell DL, Que LG, Francisco D, Church TD, Potts-Kant EN, et al. Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype. Am J Respir Crit Care Med 2012;186:404–411
   PubMed Web of Science ®Google Scholar
• Kim YH, Park CS, Lim DH, Ahn SH, Son BK, Kim JH, Jang TY. Beneficial effect of anti-interleukin-33 on the murine model of allergic inflammation of the lower airway. J Asthma 2012;49:738–743
   PubMed Web of Science ®Google Scholar